Literature DB >> 7803354

Lack of effect of preoperative norfloxacin on bacterial contamination of anterior chamber aspirates after cataract surgery.

D K Chitkara1, T Manners, F Chapman, M G Stoddart, D Hill, D Jenkins.   

Abstract

Eighty patients undergoing routine standardised extracapsular cataract surgery with lens implantation were divided randomly into two groups in a prospective double blind study comparing effects of preoperative norfloxacin eyedrops with placebo on bacterial contamination of anterior chamber aspirates after surgery. Pathogenic organisms were identified from 19 (24%) of the aspirates. The most commonly isolated organisms were coagulase negative Staphylococcus species. There was no statistical difference between the norfloxacin treated and placebo groups. This study demonstrates that routine use of topical preoperative antibiotics to eliminate the entry of bacteria into the eye during surgery is debatable.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803354      PMCID: PMC504932          DOI: 10.1136/bjo.78.10.772

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Prophylactic antibiotics and postoperative endophthalmitis.

Authors:  A E Kolker; M I Freeman; T H Pettit
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

Review 2.  Prophylactic antibiotics for ophthalmic surgery.

Authors:  M B Starr
Journal:  Surv Ophthalmol       Date:  1983 May-Jun       Impact factor: 6.048

3.  The FDA report on intraocular lenses.

Authors:  W J Stark; D M Worthen; J T Holladay; P E Bath; M E Jacobs; G C Murray; E T McGhee; M W Talbott; M D Shipp; N E Thomas; R W Barnes; D W Brown; J N Buxton; R D Reinecke; C S Lao; S Fisher
Journal:  Ophthalmology       Date:  1983-04       Impact factor: 12.079

4.  Complement levels in normal and inflamed aqueous humor.

Authors:  B J Mondino; H Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-03       Impact factor: 4.799

5.  Etiology and diagnosis of bacterial postoperative endophthalmitis.

Authors:  R K Forster
Journal:  Ophthalmology       Date:  1978-04       Impact factor: 12.079

6.  Infectious endophthalmitis. Review of 36 cases.

Authors:  C A Puliafito; A S Baker; J Haaf; C S Foster
Journal:  Ophthalmology       Date:  1982-08       Impact factor: 12.079

7.  Immunoglobulins in human aqueous humour.

Authors:  D K Sen; G S Sarin; K Saha
Journal:  Br J Ophthalmol       Date:  1977-03       Impact factor: 4.638

8.  Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans.

Authors:  M Barza; B Doft; E Lynch
Journal:  Arch Ophthalmol       Date:  1993-04

9.  Protective barrier effect of the posterior lens capsule in exogenous bacterial endophthalmitis--an experimental primate study.

Authors:  T L Beyer; G Vogler; D Sharma; F E O'Donnell
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-01       Impact factor: 4.799

10.  In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.

Authors:  D L Shungu; V K Tutlane; E Weinberg; H H Gadebusch
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

View more
  4 in total

1.  Peroperative microbial contamination of anterior chamber aspirates during extracapsular cataract extraction and phacoemulsification.

Authors:  B Beigi; W Westlake; E Mangelschots; B Chang; W Rich; T Riordan
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

Review 2.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

3.  Anterior chamber aspirate cultures in small incision cataract surgery.

Authors:  T D Manners; D K Chitkara; P J Marsh; M G Stoddart
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

Review 4.  Aqueous contamination during small incision cataract surgery: a lesson in study design.

Authors:  H Towler
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.